CME Group (CME) Financials

$262.87 -0.82 (-0.31%)

Closing price 04:00 PM Eastern

Extended Trading

$264.44 +1.57 (+0.60%)

As of 06:10 PM Eastern

Annual Income Statements for CME Group

This table shows CME Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	1,247	1,534	4,063	1,961	4,233	2,105	2,617	2,657	3,186	3,482
Consolidated Net Income / (Loss)	1,247	1,534	4,063	1,962	4,232	2,106	2,637	2,691	3,226	3,526
Net Income / (Loss) Continuing Operations	1,247	1,534	4,063	1,964	4,232	2,106	2,637	2,691	3,226	3,526
Total Pre-Tax Income	1,957	2,288	2,526	2,778	2,690	2,722	3,374	3,490	4,154	4,541
Total Operating Income	1,989	2,201	2,311	2,608	2,588	2,637	2,645	3,016	3,436	3,932
Total Gross Profit	2,649	3,052	3,081	3,520	3,969	4,027	3,853	4,266	4,750	5,280
Total Revenue	3,327	3,595	3,645	4,309	4,868	4,884	4,690	5,019	5,579	6,130
Operating Revenue	3,269	3,595	3,645	4,309	4,868	4,884	4,690	5,019	5,579	6,130
Total Cost of Revenue	678	543	564	789	899	857	837	753	829	850
Operating Cost of Revenue	678	543	564	789	899	857	837	753	829	850
Total Operating Expenses	661	852	770	912	1,382	1,390	1,208	1,250	1,315	1,348
Selling, General & Admin Expense	247	393	314	493	535	482	393	379	421	400
Depreciation Expense	129	129	113	119	159	153	148	135	126	115
Amortization Expense	99	96	96	130	315	311	238	228	227	222
Other Operating Expenses / (Income)	185	233	248	171	374	443	430	509	542	611
Total Other Income / (Expense), net	-32	87	216	170	102	85	728	474	718	610
Interest Expense	117	124	117	158	178	166	167	163	159	161
Interest & Investment Income	130	252	661	898	815	373	553	2,500	5,572	4,430
Other Income / (Expense), net	-45	-41	-328	-570	-535	-122	343	-1,862	-4,695	-3,659
Income Tax Expense	710	754	-1,537	814	574	616	737	799	927	1,016
Basic Earnings per Share	$3.71	$4.55	$12.00	$5.73	$5.93	$5.88	$7.30	$7.41	$8.87	$9.69
Weighted Average Basic Shares Outstanding	336.22M	337.50M	338.71M	342.34M	357.16M	357.76M	358.34M	358.71M	359.02M	359.39M
Diluted Earnings per Share	$3.69	$4.53	$11.94	$5.71	$5.91	$5.87	$7.29	$7.40	$8.86	$9.67
Weighted Average Diluted Shares Outstanding	337.89M	338.97M	340.23M	343.74M	358.24M	358.52M	358.93M	359.18M	359.50M	359.94M
Weighted Average Basic & Diluted Shares Outstanding	338.42M	339.65M	340.39M	342.34M	357.16M	359.01M	359.40M	359.72M	359.99M	360.36M
Cash Dividends to Common per Share	$4.90	$5.65	$6.14	$4.55	$5.50	$5.90	$6.85	-	-	$10.40

This table shows CME Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	680	604	884	778	750	774	855	883	913	830
Consolidated Net Income / (Loss)	680	638	884	778	750	815	855	883	913	875
Net Income / (Loss) Continuing Operations	680	638	884	778	750	815	855	883	913	875
Total Pre-Tax Income	880	827	1,157	1,016	974	1,006	1,113	1,155	1,177	1,097
Total Operating Income	739	668	914	839	820	863	960	1,001	1,024	947
Total Gross Profit	1,038	1,015	1,237	1,155	1,132	1,226	1,282	1,328	1,366	1,305
Total Revenue	1,228	1,208	1,442	1,360	1,338	1,439	1,488	1,533	1,584	1,525
Operating Revenue	1,228	1,208	1,442	1,360	1,338	1,439	1,488	1,533	1,584	1,525
Total Cost of Revenue	190	193	205	206	206	213	206	205	219	221
Operating Cost of Revenue	190	193	205	206	206	213	206	205	219	221
Total Operating Expenses	299	347	323	316	312	363	322	327	341	357
Selling, General & Admin Expense	79	134	99	95	89	138	90	93	93	124
Depreciation Expense	35	34	32	32	31	31	30	29	28	28
Amortization Expense	56	57	57	57	57	56	55	56	56	55
Other Operating Expenses / (Income)	130	122	136	132	135	139	147	150	164	150
Total Other Income / (Expense), net	141	159	243	178	154	143	154	154	153	150
Interest Expense	40	40	40	40	40	40	40	40	40	41
Interest & Investment Income	763	1,216	1,436	1,643	1,349	1,144	1,159	1,131	1,113	1,028
Other Income / (Expense), net	-581	-1,017	-1,153	-1,425	-1,156	-961	-965	-937	-920	-838
Income Tax Expense	200	189	273	239	224	191	258	271	264	222
Basic Earnings per Share	$1.87	$1.76	$2.43	$2.14	$2.06	$2.24	$2.35	$2.43	$2.51	$2.40
Weighted Average Basic Shares Outstanding	358.72M	358.71M	358.93M	358.94M	359.02M	359.02M	359.26M	359.33M	359.40M	359.39M
Diluted Earnings per Share	$1.87	$1.76	$2.43	$2.14	$2.06	$2.23	$2.35	$2.42	$2.50	$2.40
Weighted Average Diluted Shares Outstanding	359.29M	359.18M	359.31M	359.43M	359.62M	359.50M	359.83M	359.87M	359.99M	359.94M
Weighted Average Basic & Diluted Shares Outstanding	359.73M	359.72M	359.72M	719.50M	719.99M	359.99M	720.13M	720.19M	360.36M	360.36M

This table details how cash moves in and out of CME Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	327	165	-54	-529	-2,199	49,787	72,370	-22,816	-44,865	8,684
Net Cash From Operating Activities	1,533	1,732	-1,751	2,441	2,673	2,716	2,402	3,056	3,454	3,691
Net Cash From Continuing Operating Activities	1,524	1,732	1,751	2,441	2,673	2,716	2,402	3,056	3,454	3,691
Net Income / (Loss) Continuing Operations	1,247	1,534	4,063	1,964	2,116	2,106	2,637	2,691	3,226	3,526
Consolidated Net Income / (Loss)	1,247	1,534	4,063	1,964	2,116	2,106	2,637	2,691	3,226	3,526
Depreciation Expense	129	129	113	119	159	153	148	135	126	115
Amortization Expense	99	96	96	130	315	311	238	228	227	222
Non-Cash Adjustments To Reconcile Net Income	189	43	-2,415	10	104	129	-438	56	-64	83
Changes in Operating Assets and Liabilities, net	-132	-70	-105	226	-21	16	-182	-54	-61	-255
Net Cash From Investing Activities	18	54	180	-1,890	-153	-176	58	-490	21	-83
Net Cash From Continuing Investing Activities	18	54	180	-1,890	-153	-176	58	-490	21	-83
Purchase of Property, Plant & Equipment	-114	-92	-82	-117	-246	-198	-127	-90	-76	-94
Acquisitions	-	0.00	0.00	-1,795	0.00	0.00	-53	-410	0.00	0.00
Purchase of Investments	-45	-55	-8.30	-10	-15	-17	-12	-7.50	-6.50	-8.10
Sale and/or Maturity of Investments	177	192	2.50	12	108	39	111	17	104	20
Net Cash From Financing Activities	-1,224	-1,621	-1,985	-1,080	-4,719	47,247	69,909	-25,382	-48,339	5,077
Net Cash From Continuing Financing Activities	-1,224	-1,621	-1,985	-1,080	-4,719	47,247	69,909	-25,382	-48,339	5,077
Repayment of Debt	-671	2.20	40	-437	-624	-2.20	-3.10	-764	-26	-9.20
Payment of Dividends	-1,343	-1,787	-1,994	-2,150	-1,696	-2,110	-2,189	-2,634	-3,236	-3,584
Issuance of Debt	744	0.00	0.00	387	-	-305	0.00	741	0.00	0.00
Other Financing Activities, net	47	165	-31	-65	-2,399	49,663	71,136	-22,725	-45,078	8,670
Cash Interest Paid	89	85	85	108	146	133	133	133	130	130
Cash Income Taxes Paid	717	707	763	577	591	653	755	973	1,109	1,198

This table details how cash moves in and out of CME Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	1,795	-4,135	-8,313	-14,534	-25,630	3,612	2,806	-8,451	14,321	8.50
Net Cash From Operating Activities	658	982	902	650	857	1,044	893	777	1,003	1,018
Net Cash From Continuing Operating Activities	658	982	902	650	857	1,044	893	777	1,003	1,018
Net Income / (Loss) Continuing Operations	680	638	884	778	750	815	855	883	913	875
Consolidated Net Income / (Loss)	680	638	884	778	750	815	855	883	913	875
Depreciation Expense	35	34	32	32	31	31	30	29	28	28
Amortization Expense	56	57	57	57	57	56	55	56	56	55
Non-Cash Adjustments To Reconcile Net Income	12	2.60	-39	10	37	-73	24	-8.50	30	38
Changes in Operating Assets and Liabilities, net	-124	250	-31	-227	-19	216	-72	-182	-23	22
Net Cash From Investing Activities	-24	-26	-17	78	-20	-20	-23	-5.00	-30	-25
Net Cash From Continuing Investing Activities	-24	-26	-17	78	-20	-20	-23	-5.00	-30	-25
Purchase of Property, Plant & Equipment	-24	-24	-15	-21	-20	-21	-20	-18	-30	-26
Purchase of Investments	-0.80	-2.70	-2.70	-2.30	-0.40	-1.10	-4.70	-1.90	-1.30	-0.20
Sale and/or Maturity of Investments	1.20	1.40	0.70	101	0.80	1.50	1.70	15	1.60	1.10
Net Cash From Financing Activities	1,161	-5,091	-9,199	-15,263	-26,467	2,589	1,936	-9,223	13,347	-984
Net Cash From Continuing Financing Activities	1,161	-5,091	-9,199	-15,263	-26,467	2,589	1,936	-9,223	13,347	-984
Repayment of Debt	-4.30	1.00	-4.10	-13	-	-8.90	-4.30	-0.30	-4.40	-0.20
Payment of Dividends	-363	-364	-2,036	-400	-400	-400	-2,328	-419	-419	-419
Other Financing Activities, net	1,528	-4,729	-7,159	-14,850	-26,067	2,998	4,269	-8,804	13,770	-565
Cash Interest Paid	41	25	41	24	41	24	41	24	41	24
Cash Income Taxes Paid	325	169	31	581	272	226	115	535	289	259

This table presents CME Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	67,359	69,369	75,791	77,476	75,215	124,660	196,780	174,176	129,706	137,447
Total Current Assets	37,905	40,032	46,907	41,887	39,568	89,284	161,762	139,078	94,890	103,034
Cash & Equivalents	1,693	1,869	1,904	1,375	1,551	1,633	2,835	2,720	2,912	2,892
Short-Term Investments	73	83	90	73	83	101	115	96	112	113
Accounts Receivable	358	364	360	553	492	461	435	483	536	573
Other Current Assets	35,782	37,715	44,553	39,886	37,441	87,089	158,377	135,779	91,331	99,455
Plant, Property, & Equipment, net	492	425	400	449	544	579	505	456	410	386
Total Noncurrent Assets	28,963	28,913	28,485	35,140	35,104	34,797	34,513	34,642	34,406	34,027
Goodwill	7,569	7,569	7,569	10,805	10,743	10,799	10,528	10,483	10,495	10,487
Intangible Assets	19,713	19,617	19,522	22,675	22,293	17,175	20,707	20,445	20,226	19,997
Other Noncurrent Operating Assets	1,681	1,727	1,394	1,660	2,068	1,957	3,278	3,714	3,686	3,544
Total Liabilities & Shareholders' Equity	67,359	69,369	75,791	77,476	75,215	124,660	196,780	174,176	129,706	137,447
Total Liabilities	46,808	49,029	53,379	51,510	49,056	98,308	169,381	147,297	102,968	110,960
Total Current Liabilities	36,825	38,946	45,673	41,273	38,523	88,198	160,398	137,688	93,417	102,314
Short-Term Debt	-	-	0.00	574	-	0.00	749	16	0.00	750
Accounts Payable	29	26	31	116	62	69	49	121	91	80
Other Current Liabilities	36,796	38,919	45,642	40,582	38,461	88,129	159,600	137,550	93,326	101,484
Total Noncurrent Liabilities	9,983	10,083	7,707	10,238	10,534	10,110	8,983	9,610	9,551	8,646
Long-Term Debt	2,229	2,231	2,233	3,827	3,743	3,444	2,696	3,422	3,425	2,678
Noncurrent Deferred & Payable Income Tax Liabilities	7,358	7,291	4,858	5,666	5,635	5,607	5,390	5,361	5,328	5,247
Other Noncurrent Operating Liabilities	396	561	616	745	1,155	1,059	897	826	798	721
Total Equity & Noncontrolling Interests	20,552	20,341	22,412	25,965	26,159	26,352	27,399	26,879	26,738	26,487
Total Preferred & Common Equity	20,552	20,341	22,412	25,919	26,129	26,320	27,399	26,879	26,738	26,487
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	20,552	20,341	22,412	25,919	26,129	26,320	27,399	26,879	26,738	26,487
Common Stock	17,725	17,830	17,900	21,058	21,117	21,189	22,194	22,265	22,338	22,407
Retained Earnings	2,908	2,525	4,497	4,855	5,009	4,996	5,152	4,747	4,455	4,186
Accumulated Other Comprehensive Income / (Loss)	-81	-14	14	5.30	3.40	135	54	-133	-56	-106

This table presents CME Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	178,432	174,176	166,039	151,297	125,598	129,706	132,054	123,379	137,795	137,447
Total Current Assets	143,253	139,078	131,032	116,366	90,777	94,890	97,308	88,749	103,143	103,034
Cash & Equivalents	2,130	2,720	1,565	1,880	2,300	2,912	1,437	1,790	2,322	2,892
Short-Term Investments	91	96	105	107	104	112	121	122	112	113
Accounts Receivable	580	483	724	599	558	536	628	600	629	573
Other Current Assets	140,451	135,779	128,638	113,780	87,814	91,331	95,122	86,238	100,079	99,455
Plant, Property, & Equipment, net	466	456	440	430	417	410	396	385	386	386
Total Noncurrent Assets	34,713	34,642	34,567	34,501	34,404	34,406	34,350	34,246	34,266	34,027
Goodwill	10,447	10,483	10,491	10,491	10,478	10,495	10,490	10,489	10,514	10,487
Intangible Assets	20,478	20,445	20,393	20,336	20,271	20,226	20,165	20,108	20,068	19,997
Other Noncurrent Operating Assets	3,788	3,714	3,684	3,674	3,656	3,686	3,695	3,650	3,685	3,544
Total Liabilities & Shareholders' Equity	178,432	174,176	166,039	151,297	125,598	129,706	132,054	123,379	137,795	137,447
Total Liabilities	150,181	147,297	138,655	123,479	97,447	102,968	104,900	95,744	109,579	110,960
Total Current Liabilities	140,573	137,688	129,044	113,886	87,881	93,417	96,101	86,974	100,822	102,314
Short-Term Debt	15	16	16	0.00	0.00	0.00	749	750	750	750
Accounts Payable	95	121	97	51	54	91	111	100	130	80
Other Current Liabilities	140,463	137,550	128,930	113,835	87,827	93,326	95,241	86,125	99,942	101,484
Total Noncurrent Liabilities	9,608	9,610	9,611	9,593	9,566	9,551	8,798	8,770	8,757	8,646
Long-Term Debt	3,422	3,422	3,423	3,424	3,425	3,425	2,677	2,677	2,678	2,678
Noncurrent Deferred & Payable Income Tax Liabilities	5,352	5,361	5,357	5,344	5,333	5,328	5,317	5,309	5,310	5,247
Other Noncurrent Operating Liabilities	835	826	831	826	809	798	804	783	769	721
Total Equity & Noncontrolling Interests	28,251	26,879	27,384	27,818	28,152	26,738	27,154	27,636	28,216	26,487
Total Preferred & Common Equity	28,251	26,879	27,384	27,818	28,152	26,738	27,154	27,636	28,216	26,487
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	28,251	26,879	27,384	27,818	28,152	26,738	27,154	27,636	28,216	26,487
Common Stock	22,239	22,265	22,285	22,311	22,313	22,338	22,349	22,376	22,379	22,407
Retained Earnings	6,112	4,747	5,230	5,607	5,956	4,455	4,891	5,355	5,848	4,186
Accumulated Other Comprehensive Income / (Loss)	-100	-133	-131	-100	-117	-56	-86	-95	-11	-106

This table displays calculated financial ratios and metrics derived from CME Group's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.89%	8.07%	1.38%	18.24%	12.96%	0.32%	-3.97%	7.03%	11.15%	9.88%
EBITDA Growth	8.45%	9.74%	-8.12%	4.35%	10.49%	17.94%	13.22%	-55.05%	-159.80%	167.19%
EBIT Growth	9.82%	11.06%	-8.18%	2.78%	0.75%	22.51%	18.80%	-61.39%	-209.16%	121.62%
NOPAT Growth	12.65%	16.44%	151.85%	-50.40%	10.43%	0.25%	1.31%	12.46%	14.77%	14.38%
Net Income Growth	10.66%	23.02%	164.87%	-51.71%	115.66%	-50.22%	25.19%	2.05%	19.89%	9.29%
EPS Growth	10.15%	22.76%	163.58%	-52.18%	3.50%	-0.68%	24.19%	1.51%	19.73%	9.14%
Operating Cash Flow Growth	18.67%	13.02%	-201.10%	239.39%	9.51%	1.60%	-11.53%	27.21%	13.02%	6.85%
Free Cash Flow Firm Growth	81.67%	1.62%	-9.96%	-362.53%	160.73%	164.74%	-136.99%	203.33%	11.45%	8.34%
Invested Capital Growth	-2.66%	-1.88%	9.85%	27.67%	-2.25%	-17.94%	20.26%	-1.41%	-1.31%	-0.85%
Revenue Q/Q Growth	-0.81%	2.83%	-0.35%	8.47%	-1.98%	-0.81%	1.05%	1.22%	4.33%	1.42%
EBITDA Q/Q Growth	-0.11%	2.58%	-4.49%	4.82%	0.11%	1.00%	5.67%	-41.12%	21.39%	50.62%
EBIT Q/Q Growth	-0.12%	2.78%	-4.66%	3.29%	-1.04%	1.00%	7.44%	-47.77%	16.62%	320.87%
NOPAT Q/Q Growth	-0.98%	3.01%	173.29%	-56.11%	2.77%	-1.03%	4.35%	0.89%	7.33%	1.88%
Net Income Q/Q Growth	-1.17%	5.63%	171.33%	-56.55%	108.22%	-50.63%	8.22%	0.47%	5.79%	1.73%
EPS Q/Q Growth	-1.07%	5.35%	170.75%	-56.94%	4.05%	-2.17%	7.52%	0.96%	5.60%	1.79%
Operating Cash Flow Q/Q Growth	-6.77%	6.67%	-197.81%	319.61%	8.50%	-2.14%	0.33%	11.42%	1.85%	-0.71%
Free Cash Flow Firm Q/Q Growth	11.45%	20.59%	-14.64%	-1,358.48%	222.71%	192.67%	-148.32%	270.31%	8.99%	10.94%
Invested Capital Q/Q Growth	-4.95%	-6.24%	5.96%	14.64%	-3.84%	-20.09%	9.11%	-6.67%	-6.97%	-7.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.64%	84.89%	84.53%	81.68%	81.54%	82.46%	82.15%	85.00%	85.15%	86.13%
EBITDA Margin	65.31%	66.32%	60.11%	53.05%	51.89%	61.01%	71.93%	30.20%	-16.25%	9.94%
Operating Margin	59.78%	61.21%	63.40%	60.51%	53.16%	54.01%	56.40%	60.08%	61.58%	64.13%
EBIT Margin	58.44%	60.06%	54.39%	47.28%	42.17%	51.50%	63.71%	22.98%	-22.57%	4.44%
Profit (Net Income) Margin	37.48%	42.67%	111.49%	45.53%	86.93%	43.13%	56.23%	53.61%	57.83%	57.52%
Tax Burden Percent	63.73%	67.06%	160.84%	70.64%	157.33%	77.38%	78.16%	77.10%	77.67%	77.64%
Interest Burden Percent	100.65%	105.95%	127.44%	136.33%	131.01%	108.23%	112.91%	302.58%	-329.86%	1,667.79%
Effective Tax Rate	36.27%	32.94%	-60.84%	29.31%	21.33%	22.62%	21.84%	22.90%	22.33%	22.36%
Return on Invested Capital (ROIC)	5.95%	7.09%	17.18%	7.15%	7.12%	7.93%	8.09%	8.40%	9.77%	11.29%
ROIC Less NNEP Spread (ROIC-NNEP)	2.36%	22.80%	150.95%	14.59%	93.88%	-4.59%	-34.71%	73.86%	118.68%	126.21%
Return on Net Nonoperating Assets (RNNOA)	0.06%	0.41%	1.83%	0.96%	9.12%	0.09%	1.72%	1.52%	2.27%	1.95%
Return on Equity (ROE)	6.01%	7.50%	19.01%	8.11%	16.24%	8.02%	9.81%	9.92%	12.03%	13.25%
Cash Return on Invested Capital (CROIC)	8.65%	8.99%	7.79%	-17.16%	9.40%	27.64%	-10.30%	9.82%	11.09%	12.15%
Operating Return on Assets (OROA)	2.79%	3.16%	2.73%	2.66%	2.69%	2.52%	1.86%	0.62%	-0.83%	0.20%
Return on Assets (ROA)	1.79%	2.24%	5.60%	2.56%	5.54%	2.11%	1.64%	1.45%	2.12%	2.64%
Return on Common Equity (ROCE)	6.01%	7.50%	19.01%	8.10%	16.21%	8.01%	9.81%	9.92%	12.03%	13.25%
Return on Equity Simple (ROE_SIMPLE)	6.07%	7.54%	18.13%	7.57%	16.20%	8.00%	9.62%	10.01%	12.07%	13.31%
Net Operating Profit after Tax (NOPAT)	1,267	1,476	3,716	1,843	2,036	2,041	2,068	2,325	2,669	3,052
NOPAT Margin	38.09%	41.05%	101.97%	42.78%	41.82%	41.79%	44.09%	46.33%	47.83%	49.79%
Net Nonoperating Expense Percent (NNEP)	3.59%	-15.71%	-133.77%	-7.44%	-86.76%	12.52%	42.80%	-65.46%	-108.91%	-114.92%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	7.67%	8.85%	10.20%
Cost of Revenue to Revenue	20.36%	15.11%	15.47%	18.32%	18.46%	17.54%	17.85%	15.00%	14.85%	13.87%
SG&A Expenses to Revenue	7.43%	10.93%	8.61%	11.44%	10.98%	9.87%	8.37%	7.55%	7.54%	6.53%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.86%	23.68%	21.13%	21.17%	28.38%	28.46%	25.75%	24.91%	23.56%	21.99%
Earnings before Interest and Taxes (EBIT)	1,944	2,159	1,982	2,038	2,053	2,515	2,988	1,154	-1,259	272
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,173	2,384	2,191	2,286	2,526	2,979	3,373	1,516	-907	609
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.09	1.48	1.78	2.03	2.33	2.17	2.70	2.05	2.71	3.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	6.71	8.35	10.93	12.23	12.49	11.68	15.76	10.98	12.98	13.65
Price to Earnings (P/E)	17.91	19.57	9.80	26.89	14.36	27.09	28.25	20.74	22.74	24.04
Dividend Yield	7.42%	6.39%	5.25%	2.94%	3.24%	3.71%	3.33%	5.55%	4.80%	4.48%
Earnings Yield	5.58%	5.11%	10.20%	3.72%	6.96%	3.69%	3.54%	4.82%	4.40%	4.16%
Enterprise Value to Invested Capital (EV/IC)	1.09	1.47	1.77	1.93	2.23	2.53	2.67	2.03	2.68	3.13
Enterprise Value to Revenue (EV/Rev)	6.85	8.43	11.00	12.93	12.93	12.04	15.87	11.11	13.06	13.72
Enterprise Value to EBITDA (EV/EBITDA)	10.50	12.71	18.29	24.37	24.91	19.73	22.06	36.77	0.00	138.09
Enterprise Value to EBIT (EV/EBIT)	11.73	14.03	20.22	27.35	30.66	23.37	24.91	48.33	0.00	308.88
Enterprise Value to NOPAT (EV/NOPAT)	17.99	20.53	10.78	30.23	30.91	28.80	36.00	23.97	27.30	27.56
Enterprise Value to Operating Cash Flow (EV/OCF)	14.88	17.49	0.00	22.83	23.55	21.64	30.98	18.24	21.09	22.79
Enterprise Value to Free Cash Flow (EV/FCFF)	12.38	16.19	23.78	0.00	23.42	8.26	0.00	20.50	24.04	25.62
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.11	0.10	0.17	0.14	0.13	0.13	0.13	0.13	0.13
Long-Term Debt to Equity	0.11	0.11	0.10	0.15	0.14	0.13	0.10	0.13	0.13	0.10
Financial Leverage	0.03	0.02	0.01	0.07	0.10	-0.02	-0.05	0.02	0.02	0.02
Leverage Ratio	3.37	3.34	3.40	3.17	2.93	3.81	5.98	6.83	5.67	5.02
Compound Leverage Factor	3.39	3.54	4.33	4.32	3.84	4.12	6.75	20.68	-18.70	83.71
Debt to Total Capital	9.79%	9.88%	9.06%	14.49%	12.52%	11.56%	11.17%	11.34%	11.36%	11.46%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	1.89%	0.00%	0.00%	2.43%	0.05%	0.00%	2.51%
Long-Term Debt to Total Capital	9.79%	9.88%	9.06%	12.60%	12.52%	11.56%	8.74%	11.29%	11.36%	8.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.15%	0.10%	0.11%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	90.21%	90.12%	90.94%	85.35%	87.38%	88.34%	88.83%	88.66%	88.64%	88.54%
Debt to EBITDA	1.03	0.94	1.02	1.92	1.48	1.16	1.02	2.27	-3.78	5.63
Net Debt to EBITDA	0.21	0.12	0.11	1.29	0.83	0.57	0.15	0.41	-0.44	0.69
Long-Term Debt to EBITDA	1.03	0.94	1.02	1.67	1.48	1.16	0.80	2.26	-3.78	4.40
Debt to NOPAT	1.76	1.51	0.60	2.39	1.84	1.69	1.67	1.48	1.28	1.12
Net Debt to NOPAT	0.37	0.19	0.06	1.60	1.04	0.84	0.24	0.27	0.15	0.14
Long-Term Debt to NOPAT	1.76	1.51	0.60	2.08	1.84	1.69	1.30	1.47	1.28	0.88
Altman Z-Score	0.51	0.59	0.68	0.85	1.01	0.52	0.38	0.32	0.49	0.55
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.10%	0.15%	0.12%	0.06%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.03	1.03	1.03	1.01	1.03	1.01	1.01	1.01	1.02	1.01
Quick Ratio	0.06	0.06	0.05	0.05	0.06	0.02	0.02	0.02	0.04	0.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,842	1,872	1,685	-4,424	2,687	7,113	-2,631	2,719	3,030	3,283
Operating Cash Flow to CapEx	1,341.94%	1,886.71%	-2,138.10%	2,091.52%	1,088.27%	1,374.99%	2,733.11%	3,406.91%	4,520.68%	3,926.06%
Free Cash Flow to Firm to Interest Expense	15.69	15.16	14.40	-28.06	15.09	42.80	-15.76	16.71	19.01	20.40
Operating Cash Flow to Interest Expense	13.05	14.02	-14.97	15.48	15.02	16.34	14.39	18.78	21.67	22.94
Operating Cash Flow Less CapEx to Interest Expense	12.08	13.28	-15.67	14.74	13.64	15.15	13.87	18.23	21.19	22.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.05	0.05	0.05	0.06	0.06	0.05	0.03	0.03	0.04	0.05
Accounts Receivable Turnover	9.52	9.96	10.07	9.44	9.32	10.25	10.47	10.94	10.95	11.06
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	6.65	7.84	8.84	10.16	9.81	8.70	8.65	10.45	12.90	15.41
Accounts Payable Turnover	20.66	19.79	19.61	10.72	10.10	13.06	14.17	8.85	7.82	9.97
Days Sales Outstanding (DSO)	38.35	36.66	36.26	38.66	39.18	35.62	34.86	33.37	33.33	33.01
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	17.67	18.44	18.61	34.05	36.13	27.96	25.75	41.24	46.69	36.59
Cash Conversion Cycle (CCC)	20.67	18.22	17.65	4.61	3.05	7.66	9.11	-7.88	-13.37	-3.59
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	21,016	20,620	22,651	28,919	28,268	23,196	27,895	27,501	27,140	26,909
Invested Capital Turnover	0.16	0.17	0.17	0.17	0.17	0.19	0.18	0.18	0.20	0.23
Increase / (Decrease) in Invested Capital	-575	-396	2,031	6,268	-651	-5,072	4,699	-394	-361	-230
Enterprise Value (EV)	22,802	30,296	40,075	55,724	62,933	58,779	74,425	55,743	72,839	84,109
Market Capitalization	22,338	30,016	39,836	52,724	60,794	57,037	73,930	55,121	72,438	83,687
Book Value per Share	$60.76	$59.94	$65.86	$76.05	$72.91	$73.32	$76.24	$74.72	$74.27	$73.50
Tangible Book Value per Share	($19.90)	($20.17)	($13.75)	($22.19)	($19.27)	($4.61)	($10.67)	($11.26)	($11.06)	($11.09)
Total Capital	22,781	22,572	24,645	30,366	29,903	29,795	30,844	30,317	30,163	29,915
Total Debt	2,229	2,231	2,233	4,401	3,743	3,444	3,445	3,438	3,425	3,428
Total Long-Term Debt	2,229	2,231	2,233	3,827	3,743	3,444	2,696	3,422	3,425	2,678
Net Debt	464	279	239	2,954	2,109	1,710	495	622	402	422
Capital Expenditures (CapEx)	114	92	82	117	246	198	88	90	76	94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-685	-866	-760	-259	-589	-648	-837	-1,409	-1,550	-1,536
Debt-free Net Working Capital (DFNWC)	1,080	1,086	1,234	1,188	1,045	1,086	2,113	1,407	1,473	1,469
Net Working Capital (NWC)	1,080	1,086	1,234	614	1,045	1,086	1,363	1,391	1,473	720
Net Nonoperating Expense (NNE)	20	-58	-347	-119	-2,196	-66	-569	-366	-558	-474
Net Nonoperating Obligations (NNO)	464	279	239	2,954	2,109	-3,156	495	622	402	422
Total Depreciation and Amortization (D&A)	229	225	209	249	473	464	385	363	353	337
Debt-free, Cash-free Net Working Capital to Revenue	-20.59%	-24.09%	-20.85%	-6.01%	-12.11%	-13.27%	-17.85%	-28.08%	-27.79%	-25.06%
Debt-free Net Working Capital to Revenue	32.46%	30.20%	33.85%	27.57%	21.47%	22.24%	45.05%	28.03%	26.41%	23.97%
Net Working Capital to Revenue	32.46%	30.20%	33.85%	14.25%	21.47%	22.24%	29.07%	27.71%	26.41%	11.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.71	$4.55	$12.00	$5.73	$5.93	$5.88	$7.30	$7.41	$8.87	$9.69
Adjusted Weighted Average Basic Shares Outstanding	336.22M	337.50M	338.71M	342.34M	357.16M	357.76M	358.34M	358.71M	359.02M	359.39M
Adjusted Diluted Earnings per Share	$3.69	$4.53	$11.94	$5.71	$5.91	$5.87	$7.29	$7.40	$8.86	$9.67
Adjusted Weighted Average Diluted Shares Outstanding	337.89M	338.97M	340.23M	343.74M	358.24M	358.52M	358.93M	359.18M	359.50M	359.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	338.42M	339.65M	340.39M	357.80M	358.41M	359.01M	359.40M	359.72M	359.99M	360.36M
Normalized Net Operating Profit after Tax (NOPAT)	1,267	1,476	1,617	1,843	2,036	2,041	2,068	2,325	2,669	3,052
Normalized NOPAT Margin	38.09%	41.05%	44.38%	42.78%	41.82%	41.79%	44.09%	46.33%	47.83%	49.79%
Pre Tax Income Margin	58.82%	63.63%	69.31%	64.46%	55.25%	55.74%	71.94%	69.54%	74.45%	74.08%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	16.56	17.48	16.94	12.92	11.53	15.13	17.90	7.09	-7.90	1.69
NOPAT to Interest Expense	10.80	11.95	31.76	11.69	11.44	12.28	12.39	14.29	16.74	18.97
EBIT Less CapEx to Interest Expense	15.59	16.74	16.24	12.18	10.15	13.94	17.38	6.54	-8.38	1.11
NOPAT Less CapEx to Interest Expense	9.82	11.21	31.06	10.95	10.06	11.09	11.86	13.74	16.26	18.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	107.73%	116.50%	49.06%	109.57%	40.08%	100.17%	83.03%	97.86%	100.29%	101.66%
Augmented Payout Ratio	107.73%	116.50%	49.06%	109.57%	40.08%	100.17%	83.03%	97.86%	100.29%	101.66%

This table displays calculated financial ratios and metrics derived from CME Group's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.62%	5.27%	7.05%	9.94%	8.96%	19.17%	3.21%	12.67%	18.43%	5.98%
EBITDA Growth	-75.76%	-132.28%	-116.63%	-179.90%	-199.76%	95.47%	153.26%	129.73%	176.12%	1,749.57%
EBIT Growth	-82.96%	-149.44%	-129.43%	-210.20%	-312.68%	71.92%	97.83%	110.86%	131.07%	211.84%
NOPAT Growth	9.99%	4.29%	4.71%	11.95%	10.69%	35.64%	5.60%	19.31%	25.78%	8.07%
Net Income Growth	-26.63%	2.03%	24.30%	17.37%	10.39%	27.70%	-3.24%	13.58%	21.67%	7.37%
EPS Growth	-27.52%	4.14%	24.62%	17.58%	10.16%	26.70%	-3.29%	13.08%	21.36%	7.62%
Operating Cash Flow Growth	4.15%	46.87%	12.93%	5.31%	30.24%	6.40%	-1.07%	19.45%	17.08%	-2.53%
Free Cash Flow Firm Growth	-183.63%	121.62%	-199.99%	-90.72%	127.78%	16.68%	129.94%	134.34%	-18.17%	-7.05%
Invested Capital Growth	15.26%	-1.41%	14.08%	12.17%	-1.00%	-1.31%	-0.45%	-0.36%	0.13%	-0.85%
Revenue Q/Q Growth	-0.76%	-1.63%	19.36%	-5.65%	-1.65%	7.59%	3.38%	3.00%	3.39%	-3.73%
EBITDA Q/Q Growth	-60.21%	-204.32%	41.80%	-230.72%	50.32%	95.27%	784.62%	84.64%	27.18%	2.61%
EBIT Q/Q Growth	-70.38%	-321.31%	31.49%	-145.38%	42.83%	70.78%	94.69%	1,325.00%	63.58%	5.18%
NOPAT Q/Q Growth	-0.44%	-9.68%	35.46%	-8.09%	-1.56%	10.68%	5.45%	3.85%	3.78%	-4.91%
Net Income Q/Q Growth	2.58%	-6.14%	38.55%	-12.02%	-3.52%	8.58%	4.98%	3.27%	3.35%	-4.18%
EPS Q/Q Growth	2.75%	-5.88%	38.07%	-11.93%	-3.74%	8.25%	5.38%	2.98%	3.31%	-4.00%
Operating Cash Flow Q/Q Growth	6.51%	49.21%	-8.06%	-27.93%	31.72%	21.90%	-14.52%	-12.97%	29.10%	1.49%
Free Cash Flow Firm Q/Q Growth	-150.91%	127.29%	-419.12%	12.71%	136.55%	14.60%	-18.11%	0.12%	-12.91%	30.18%
Invested Capital Q/Q Growth	12.97%	-6.67%	6.01%	0.35%	-0.28%	-6.97%	6.94%	0.44%	0.20%	-7.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	84.56%	84.02%	85.81%	84.88%	84.64%	85.21%	86.16%	86.64%	86.19%	85.52%
EBITDA Margin	20.17%	-21.39%	-10.43%	-36.57%	-18.47%	-0.81%	5.38%	9.65%	11.87%	12.65%
Operating Margin	60.17%	55.33%	63.38%	61.65%	61.31%	59.97%	64.49%	65.29%	64.64%	62.09%
EBIT Margin	12.84%	-28.90%	-16.59%	-43.13%	-25.07%	-6.81%	-0.35%	4.16%	6.58%	7.19%
Profit (Net Income) Margin	55.35%	52.82%	61.31%	57.17%	56.08%	56.60%	57.48%	57.63%	57.61%	57.34%
Tax Burden Percent	77.23%	77.11%	76.39%	76.51%	77.00%	80.97%	76.81%	76.50%	77.56%	79.76%
Interest Burden Percent	558.02%	-237.05%	-483.86%	-173.24%	-290.49%	-1,026.53%	-21,411.54%	1,812.40%	1,129.46%	1,000.55%
Effective Tax Rate	22.77%	22.89%	23.61%	23.49%	23.00%	19.03%	23.19%	23.50%	22.44%	20.24%
Return on Invested Capital (ROIC)	8.38%	7.73%	9.05%	8.93%	8.61%	9.92%	9.58%	9.92%	10.38%	11.23%
ROIC Less NNEP Spread (ROIC-NNEP)	-35.03%	29.67%	-81.09%	-47.40%	19.23%	32.50%	16.08%	17.89%	22.15%	40.17%
Return on Net Nonoperating Assets (RNNOA)	0.32%	0.61%	0.61%	0.41%	0.76%	0.62%	1.07%	0.95%	0.79%	0.62%
Return on Equity (ROE)	8.69%	8.34%	9.66%	9.34%	9.37%	10.54%	10.65%	10.87%	11.17%	11.86%
Cash Return on Invested Capital (CROIC)	-5.80%	9.82%	-4.54%	-2.70%	9.48%	11.09%	9.76%	10.06%	10.14%	12.15%
Operating Return on Assets (OROA)	0.35%	-0.78%	-0.46%	-1.38%	-0.88%	-0.25%	-0.01%	0.18%	0.30%	0.33%
Return on Assets (ROA)	1.50%	1.43%	1.69%	1.83%	1.97%	2.08%	2.17%	2.43%	2.64%	2.63%
Return on Common Equity (ROCE)	8.69%	8.34%	9.66%	9.34%	9.37%	10.54%	10.65%	10.87%	11.17%	11.86%
Return on Equity Simple (ROE_SIMPLE)	9.48%	0.00%	10.46%	10.71%	10.83%	0.00%	11.78%	11.95%	12.28%	0.00%
Net Operating Profit after Tax (NOPAT)	571	515	698	642	632	699	737	765	794	755
NOPAT Margin	46.47%	42.66%	48.42%	47.17%	47.21%	48.56%	49.54%	49.95%	50.14%	49.52%
Net Nonoperating Expense Percent (NNEP)	43.40%	-21.94%	90.15%	56.33%	-10.62%	-22.58%	-6.50%	-7.98%	-11.76%	-28.94%
Return On Investment Capital (ROIC_SIMPLE)	-	1.70%	-	-	-	2.32%	-	-	-	2.53%
Cost of Revenue to Revenue	15.44%	15.98%	14.19%	15.12%	15.36%	14.79%	13.85%	13.36%	13.81%	14.48%
SG&A Expenses to Revenue	6.43%	11.05%	6.85%	6.99%	6.63%	9.59%	6.03%	6.07%	5.89%	8.15%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.39%	28.69%	22.43%	23.22%	23.33%	25.23%	21.66%	21.35%	21.55%	23.43%
Earnings before Interest and Taxes (EBIT)	158	-349	-239	-587	-335	-98	-5.20	64	104	110
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	248	-258	-150	-497	-247	-12	80	148	188	193
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.06	2.05	2.39	2.29	2.44	2.71	2.84	2.56	2.82	3.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	11.73	10.98	12.78	12.15	12.86	12.98	13.70	12.21	13.15	13.65
Price to Earnings (P/E)	21.87	20.74	23.10	21.61	22.81	22.74	24.41	21.70	23.20	24.04
Dividend Yield	4.42%	5.55%	4.73%	4.92%	4.60%	4.80%	4.53%	4.96%	4.44%	4.48%
Earnings Yield	4.57%	4.82%	4.33%	4.63%	4.38%	4.40%	4.10%	4.61%	4.31%	4.16%
Enterprise Value to Invested Capital (EV/IC)	2.02	2.03	2.30	2.22	2.39	2.68	2.72	2.48	2.75	3.13
Enterprise Value to Revenue (EV/Rev)	11.97	11.11	13.13	12.43	13.05	13.06	14.03	12.47	13.31	13.72
Enterprise Value to EBITDA (EV/EBITDA)	23.06	36.77	145.54	0.00	0.00	0.00	0.00	0.00	198.93	138.09
Enterprise Value to EBIT (EV/EBIT)	26.89	48.33	658.34	0.00	0.00	0.00	0.00	0.00	1,243.41	308.88
Enterprise Value to NOPAT (EV/NOPAT)	25.76	23.97	28.49	26.83	28.08	27.30	29.14	25.52	26.85	27.56
Enterprise Value to Operating Cash Flow (EV/OCF)	21.65	18.24	21.25	20.39	20.59	21.09	22.92	20.25	21.64	22.79
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	20.50	0.00	0.00	25.11	24.04	27.79	24.62	27.19	25.62
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.12	0.13	0.13	0.12	0.12	0.13	0.13	0.12	0.12	0.13
Long-Term Debt to Equity	0.12	0.13	0.13	0.12	0.12	0.13	0.10	0.10	0.09	0.10
Financial Leverage	-0.01	0.02	-0.01	-0.01	0.04	0.02	0.07	0.05	0.04	0.02
Leverage Ratio	6.58	6.83	6.75	5.88	5.39	5.67	5.47	4.95	4.67	5.02
Compound Leverage Factor	36.70	-16.20	-32.65	-10.18	-15.66	-58.18	-1,170.30	89.77	52.78	50.22
Debt to Total Capital	10.84%	11.34%	11.16%	10.96%	10.85%	11.36%	11.20%	11.03%	10.83%	11.46%
Short-Term Debt to Total Capital	0.05%	0.05%	0.05%	0.00%	0.00%	0.00%	2.45%	2.41%	2.37%	2.51%
Long-Term Debt to Total Capital	10.80%	11.29%	11.11%	10.96%	10.85%	11.36%	8.75%	8.62%	8.46%	8.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	89.16%	88.66%	88.84%	89.04%	89.15%	88.64%	88.80%	88.97%	89.17%	88.54%
Debt to EBITDA	1.33	2.27	7.45	-5.20	-2.97	-3.78	-5.07	-111.26	8.48	5.63
Net Debt to EBITDA	0.47	0.41	3.83	-2.18	-0.88	-0.44	-2.76	-49.19	2.46	0.69
Long-Term Debt to EBITDA	1.33	2.26	7.42	-5.20	-2.97	-3.78	-3.96	-86.92	6.62	4.40
Debt to NOPAT	1.49	1.48	1.46	1.41	1.38	1.28	1.26	1.21	1.14	1.12
Net Debt to NOPAT	0.53	0.27	0.75	0.59	0.41	0.15	0.69	0.53	0.33	0.14
Long-Term Debt to NOPAT	1.48	1.47	1.45	1.41	1.38	1.28	0.99	0.95	0.89	0.88
Altman Z-Score	0.33	0.29	0.37	0.40	0.55	0.52	0.55	0.57	0.56	0.55
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.02	1.01	1.02	1.02	1.03	1.02	1.01	1.02	1.02	1.01
Quick Ratio	0.02	0.02	0.02	0.02	0.03	0.04	0.02	0.03	0.03	0.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,330	909	-2,900	-2,532	925	1,060	868	869	757	986
Operating Cash Flow to CapEx	2,740.83%	4,022.54%	5,936.84%	3,172.68%	4,305.03%	5,020.67%	4,508.59%	4,268.68%	3,365.77%	3,885.11%
Free Cash Flow to Firm to Interest Expense	-82.44	22.78	-72.69	-62.97	23.36	26.71	21.76	21.68	18.84	24.22
Operating Cash Flow to Interest Expense	16.28	24.60	22.62	16.18	21.63	26.30	22.37	19.37	24.95	25.01
Operating Cash Flow Less CapEx to Interest Expense	15.69	23.99	22.24	15.67	21.13	25.78	21.88	18.92	24.21	24.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.03	0.03	0.03	0.03	0.04	0.04	0.04	0.04	0.05	0.05
Accounts Receivable Turnover	9.44	10.94	7.68	8.86	9.39	10.95	8.32	9.67	10.18	11.06
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	10.05	10.45	10.95	11.49	12.11	12.90	13.45	14.23	15.04	15.41
Accounts Payable Turnover	9.18	8.85	8.68	12.03	10.87	7.82	7.97	11.00	9.17	9.97
Days Sales Outstanding (DSO)	38.66	33.37	47.55	41.18	38.86	33.33	43.86	37.74	35.87	33.01
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	39.77	41.24	42.06	30.34	33.58	46.69	45.77	33.19	39.80	36.59
Cash Conversion Cycle (CCC)	-1.10	-7.88	5.49	10.84	5.28	-13.37	-1.92	4.55	-3.93	-3.59
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	29,466	27,501	29,154	29,255	29,172	27,140	29,022	29,151	29,209	26,909
Invested Capital Turnover	0.18	0.18	0.19	0.19	0.18	0.20	0.19	0.20	0.21	0.23
Increase / (Decrease) in Invested Capital	3,901	-394	3,598	3,173	-294	-361	-131	-104	37	-230
Enterprise Value (EV)	59,379	55,743	67,151	65,075	69,805	72,839	78,929	72,304	80,448	84,109
Market Capitalization	58,164	55,121	65,382	63,638	68,784	72,438	77,061	70,789	79,455	83,687
Book Value per Share	$78.60	$74.72	$76.13	$77.33	$78.25	$74.27	$75.58	$76.75	$78.36	$73.50
Tangible Book Value per Share	($7.44)	($11.26)	($9.73)	($8.36)	($7.22)	($11.06)	($9.74)	($8.22)	($6.57)	($11.09)
Total Capital	31,687	30,317	30,824	31,242	31,576	30,163	30,580	31,063	31,644	29,915
Total Debt	3,436	3,438	3,439	3,424	3,425	3,425	3,426	3,427	3,427	3,428
Total Long-Term Debt	3,422	3,422	3,423	3,424	3,425	3,425	2,677	2,677	2,678	2,678
Net Debt	1,215	622	1,769	1,437	1,020	402	1,868	1,515	993	422
Capital Expenditures (CapEx)	24	24	15	21	20	21	20	18	30	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	473	-1,409	334	494	492	-1,550	398	613	636	-1,536
Debt-free Net Working Capital (DFNWC)	2,695	1,407	2,004	2,480	2,896	1,473	1,956	2,524	3,071	1,469
Net Working Capital (NWC)	2,680	1,391	1,988	2,480	2,896	1,473	1,206	1,775	2,321	720
Net Nonoperating Expense (NNE)	-109	-123	-186	-136	-119	-116	-118	-118	-118	-119
Net Nonoperating Obligations (NNO)	1,215	622	1,769	1,437	1,020	402	1,868	1,515	993	422
Total Depreciation and Amortization (D&A)	90	91	89	89	88	86	85	84	84	83
Debt-free, Cash-free Net Working Capital to Revenue	9.54%	-28.08%	6.53%	9.42%	9.20%	-27.79%	7.07%	10.56%	10.53%	-25.06%
Debt-free Net Working Capital to Revenue	54.34%	28.03%	39.19%	47.36%	54.16%	26.41%	34.77%	43.54%	50.80%	23.97%
Net Working Capital to Revenue	54.05%	27.71%	38.87%	47.36%	54.16%	26.41%	21.44%	30.61%	38.40%	11.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.87	$1.76	$2.43	$2.14	$2.06	$2.24	$2.35	$2.43	$2.51	$2.40
Adjusted Weighted Average Basic Shares Outstanding	358.72M	358.71M	358.93M	358.94M	359.02M	359.02M	359.26M	359.33M	359.40M	359.39M
Adjusted Diluted Earnings per Share	$1.87	$1.76	$2.43	$2.14	$2.06	$2.23	$2.35	$2.42	$2.50	$2.40
Adjusted Weighted Average Diluted Shares Outstanding	359.29M	359.18M	359.31M	359.43M	359.62M	359.50M	359.83M	359.87M	359.99M	359.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	359.73M	359.72M	359.72M	719.50M	719.99M	359.99M	720.13M	720.19M	360.36M	360.36M
Normalized Net Operating Profit after Tax (NOPAT)	571	515	698	642	632	699	737	765	794	755
Normalized NOPAT Margin	46.47%	42.66%	48.42%	47.17%	47.21%	48.56%	49.54%	49.95%	50.14%	49.52%
Pre Tax Income Margin	71.67%	68.50%	80.25%	74.72%	72.83%	69.90%	74.83%	75.33%	74.28%	71.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.90	-8.75	-5.99	-14.59	-8.47	-2.47	-0.13	1.59	2.59	2.69
NOPAT to Interest Expense	14.12	12.91	17.49	15.96	15.95	17.61	18.47	19.09	19.76	18.56
EBIT Less CapEx to Interest Expense	3.31	-9.36	-6.37	-15.10	-8.97	-2.99	-0.63	1.13	1.85	2.05
NOPAT Less CapEx to Interest Expense	13.53	12.30	17.11	15.45	15.45	17.08	17.98	18.64	19.02	17.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	96.96%	97.86%	109.14%	106.15%	104.90%	100.29%	110.34%	107.38%	102.88%	101.66%
Augmented Payout Ratio	96.96%	97.86%	109.14%	106.15%	104.90%	100.29%	110.34%	107.38%	102.88%	101.66%

Frequently Asked Questions About CME Group's Financials

When does CME Group's fiscal year end?

According to the most recent income statement we have on file, CME Group's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CME Group's net income changed over the last 9 years?

CME Group's net income appears to be on an upward trend, with a most recent value of $3.53 billion in 2024, rising from $1.25 billion in 2015. The previous period was $3.23 billion in 2023.

What is CME Group's operating income?

CME Group's total operating income in 2024 was $3.93 billion, based on the following breakdown:

Total Gross Profit: $5.28 billion
Total Operating Expenses: $1.35 billion

How has CME Group revenue changed over the last 9 years?

Over the last 9 years, CME Group's total revenue changed from $3.33 billion in 2015 to $6.13 billion in 2024, a change of 84.3%.

How much debt does CME Group have?

CME Group's total liabilities were at $110.96 billion at the end of 2024, a 7.8% increase from 2023, and a 137.1% increase since 2015.

How much cash does CME Group have?

In the past 9 years, CME Group's cash and equivalents has ranged from $1.37 billion in 2018 to $2.91 billion in 2023, and is currently $2.89 billion as of their latest financial filing in 2024.

How has CME Group's book value per share changed over the last 9 years?

Over the last 9 years, CME Group's book value per share changed from 60.76 in 2015 to 73.50 in 2024, a change of 21.0%.

Remove Ads

Related Companies

This page (NASDAQ:CME) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CME Group (CME) Financials

Frequently Asked Questions About CME Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CME Group (CME) Financials

Annual Income Statements for CME Group

Quarterly Income Statements for CME Group

Annual Cash Flow Statements for CME Group

Quarterly Cash Flow Statements for CME Group

Annual Balance Sheets for CME Group

Quarterly Balance Sheets for CME Group

Annual Metrics and Ratios for CME Group

Quarterly Metrics and Ratios for CME Group

Frequently Asked Questions About CME Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools